Rapid, noninvasive tool tracks neurons and biomolecules activated in the brain by psychedelic drugs

Researchers at the University of California, Davis have developed a rapid, noninvasive tool to track the neurons and biomolecules activated in the brain by psychedelic drugs.

Cancer testing company Freenome to lay off 100 employees

Freenome, a maker of blood-based cancer tests, will lay off more than 100 employees, or 20% of its workforce, a spokesperson for the company told

April 25, 2024

Risk-reducing mastectomies lower breast cancer incidence and mortality in BRCA variant carriers

A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women’s

February 17, 2024

Recipharm CEO anticipates 2024 will be ‘as hard’ for CDMOs, strategy will be key for endurance

Recipharm CEO Marc Funk anticipates 2024 to be just as challenging for CDMOs in terms of finding opportunities for growth due to wider economic challenges.

October 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.